NPI: 1093969115 · LOS ANGELES, CA 90007 · Community Health Clinic/Center · NPI assigned 11/17/2008
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 11/17/2008 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 56,841 | $1.75M |
| 2019 | 51,296 | $1.60M |
| 2020 | 29,233 | $847K |
| 2021 | 31,666 | $1.09M |
| 2022 | 42,346 | $1.61M |
| 2023 | 54,668 | $2.10M |
| 2024 | 33,962 | $1.57M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15,118 | 14,461 | $1.19M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10,280 | 9,693 | $1.05M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 20,985 | 20,047 | $966K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1,096 | 1,096 | $946K |
| J3490 | Unclassified drugs | 33,218 | 28,948 | $935K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3,883 | 3,879 | $705K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,897 | 1,854 | $600K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,275 | 3,150 | $526K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 23,760 | 23,282 | $506K |
| S4993 | Contraceptive pills for birth control | 7,751 | 7,681 | $496K |
| 87806 | 17,460 | 14,817 | $379K | |
| 11981 | 1,124 | 1,124 | $300K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 834 | 823 | $275K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 23,737 | 23,244 | $266K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 545 | 540 | $227K |
| 99201 | 2,151 | 2,094 | $166K | |
| A4267 | Contraceptive supply, condom, male, each | 26,364 | 25,594 | $134K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 329 | 329 | $129K |
| 81025 | 32,467 | 30,991 | $120K | |
| 55250 | 808 | 405 | $120K | |
| 58300 | 759 | 393 | $89K | |
| 99401 | 3,931 | 3,873 | $75K | |
| 11976 | 910 | 461 | $57K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 4,115 | 4,115 | $52K |
| 99000 | 13,952 | 13,810 | $39K | |
| S5000 | Prescription drug, generic | 5,734 | 5,341 | $38K |
| 83986 | 10,649 | 9,272 | $26K | |
| 86703 | 2,744 | 2,542 | $23K | |
| S0190 | Mifepristone, oral, 200 mg | 482 | 480 | $17K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 4,409 | 4,295 | $16K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 3,327 | 3,208 | $15K |
| 86592 | 6,336 | 6,297 | $13K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 168 | 168 | $12K |
| 99402 | 284 | 284 | $9K | |
| 82120 | 3,770 | 3,675 | $9K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 226 | 216 | $9K |
| 87210 | 3,782 | 3,688 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 600 | 598 | $5K |
| 81002 | 2,577 | 2,512 | $5K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 192 | 145 | $4K |
| 58301 | 128 | 66 | $4K | |
| 85018 | 1,186 | 1,164 | $4K | |
| 11982 | 62 | 32 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 495 | 416 | $3K |
| 59840 | 24 | 12 | $2K | |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | 14 | 14 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 137 | 137 | $1K |
| 86901 | 1,056 | 909 | $1K | |
| 36416 | 138 | 135 | $987.44 | |
| 99403 | 18 | 18 | $800.75 | |
| S0191 | Misoprostol, oral, 200 mcg | 534 | 532 | $760.54 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 37 | 37 | $104.31 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 45 | 45 | $79.55 |
| J7030 | Infusion, normal saline solution , 1000 cc | 13 | 13 | $52.00 |
| 36415 | Collection of venous blood by venipuncture | 96 | 89 | $0.00 |